Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods
- PMID: 35746548
- PMCID: PMC9228202
- DOI: 10.3390/vaccines10060940
Comparison of COVID-19 Resilience Index and Its Associated Factors across 29 Countries during the Delta and Omicron Variant Periods
Abstract
Our study aims to compare the pandemic resilience index and explore the associated factors during the Delta and Omicron variant periods. In addition, the study aims to identify the characteristics of countries that had good performances. We analyzed observation data among 29 countries over the first eight weeks during the two periods of Delta and Omicron variant dominance. Data were extracted from open public databases. The Omicron variant caused a lowered mortality rate per 100,000 COVID-19 patients; however, it is still imposing a colossal burden on health care systems. We found the percentage of the population fully vaccinated and high government indices were significantly associated with a better resilience index in both the Delta and Omicron periods. In contrast, the higher death rate of cancers and greater years lived with disability (YLD) caused by low bone density were linked with poor resilience index in the Omicron periods. Over two periods of Delta and Omicron, countries with good performance had a lower death rate from chronic diseases and lower YLD caused by nutrition deficiency and PM2.5. Our findings suggest that governments need to keep enhancing the vaccine coverage rates, developing interventions for populations with chronic diseases and nutrition deficiency to mitigate COVID-19 impacts on these targeted vulnerable cohorts.
Keywords: COVID-19; Delta; NPIs; Omicron; vaccine; variants.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Patel M.D., Rosenstrom E., Ivy J.S., Mayorga M.E., Keskinocak P., Boyce R.M., Hassmiller Lich K., Smith R.L., III, Johnson K.T., Delamater P.L., et al. Association of Simulated COVID-19 Vaccination and Nonpharmaceutical Interventions with Infections, Hospitalizations, and Mortality. JAMA Netw. Open. 2021;4:e2110782. doi: 10.1001/jamanetworkopen.2021.10782. - DOI - PMC - PubMed
-
- Johns Hopkins Coronavirus Resource Center Pandemic Data Initiative. [(accessed on 19 May 2021)]. Available online: https://coronavirus.jhu.edu/pandemic-data-initiative.
-
- Lin T.-Y., Liao S.-H., Lai C.-C., Paci E., Chuang S.-Y. Effectiveness of Non-Pharmaceutical Interventions and Vaccine for Containing the Spread of COVID-19: Three Illustrations before and after Vaccination Periods. J. Formos. Med. Assoc. 2021;120((Suppl. 1)):S46–S56. doi: 10.1016/j.jfma.2021.05.015. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
